Heat Waves, Urban Heat Islands, and Wellbeing and Health: a Mobile Sensing Approach
Launched by INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE, FRANCE · Feb 26, 2025
Trial Information
Current as of May 11, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Heat Waves, Urban Heat Islands, and Wellbeing and Health: a Mobile Sensing Approach," aims to understand how different factors, like the environment and our daily activities, affect how we experience heat stress during warm weather. The researchers want to find out how heat stress impacts our health and well-being, including how it affects our sleep and comfort levels.
To be eligible for this study, participants should be between 30 and 64 years old and live in the Ile-de-France region. Unfortunately, some people cannot participate, including those with certain heart conditions, those who are pregnant or breastfeeding, or anyone who works night shifts. If you join the study, you can expect to wear a device that helps track how your body responds to heat during daily activities. This trial is currently recruiting participants, and your involvement could help improve our understanding of how heat affects everyday life for many people.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Person aged between 30-64 years
- • Person living in the Ile-de-France
- Exclusion Criteria:
- • Person subject to a legal protection measure (safeguarding of justice, curatorship, guardianship)
- • Person deprived of liberty by a judicial or administrative decision,
- • Person with a major functional limitation affecting their spatial mobility
- • Person unable to complete a questionnaire
- • Known cardiovascular (other than hypertension) or cerebrovascular disease: personal history of myocardial infarction, rhythm disorders or stroke
- • People wearing a pacemaker or other implanted device, due to the risk of interference
- • Pregnant or breastfeeding woman
- • Person working night or shift
- • Person with a definite plan to move in the coming months (before the second collection during summer)
- • Person who initially refuses to participate in this second wave of the study
- • Person working outside the Ile de France
About Institut National De La Santé Et De La Recherche Médicale, France
The Institut National de la Santé et de la Recherche Médicale (INSERM) is France's key public research organization dedicated to advancing knowledge in health and biomedical sciences. Established to foster innovation and improve public health outcomes, INSERM conducts a wide range of clinical trials and research initiatives aimed at translating scientific discoveries into effective medical treatments and interventions. With a focus on collaboration among researchers, healthcare professionals, and industry partners, INSERM plays a pivotal role in shaping health policies and enhancing the quality of care in France and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported